VOYA Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.48M Buy
302,141
+253,309
+519% +$3.88M 0.01% 767
2026
Q1
$678K Buy
48,832
+3,963
+9% +$63.1K ﹤0.01% 1605
2025
Q4
$729K Sell
44,869
-1,259,740
-97% -$20.6M ﹤0.01% 1605
2025
Q3
$19.5M Sell
1,304,609
-255,297
-16% -$3.11M 0.02% 506
2025
Q2
$18.2M Sell
1,559,906
-446,034
-22% -$4.05M 0.02% 560
2025
Q1
$14.9M Sell
2,005,940
-422,770
-17% -$3.25M 0.02% 621
2024
Q4
$14.6M Buy
2,428,710
+2,389,674
+6,122% +$13.2M 0.02% 633
2024
Q3
$200K Sell
39,036
-366
-0.9% -$1.59K ﹤0.01% 2481
2024
Q2
$143K Sell
39,402
-216
-0.5% -$686 ﹤0.01% 2575
2024
Q1
$127K Sell
39,618
-8,093
-17% -$31.3K ﹤0.01% 2578
2023
Q4
$234K Hold
47,711
﹤0.01% 2495
2023
Q3
$260K Buy
47,711
+1,044
+2% +$6.9K ﹤0.01% 2387
2023
Q2
$313K Buy
46,667
+1,798
+4% +$13.4K ﹤0.01% 2340
2023
Q1
$396K Buy
44,869
+1,748
+4% +$15.4K ﹤0.01% 2175
2022
Q4
$329K Hold
43,121
﹤0.01% 2269
2022
Q3
$307K Buy
43,121
+1,677
+4% +$15.8K ﹤0.01% 2335
2022
Q2
$335K Sell
41,444
-7,651
-16% -$67.3K ﹤0.01% 2099
2022
Q1
$681K Sell
49,095
-933
-2% -$14.7K ﹤0.01% 1724
2021
Q4
$1.4M Buy
50,028
+17,508
+54% +$537K ﹤0.01% 1347
2021
Q3
$1.1M Sell
32,520
-638
-2% -$23.1K ﹤0.01% 1494
2021
Q2
$1.35M Buy
33,158
+7,853
+31% +$305K ﹤0.01% 1419
2021
Q1
$1.02M Sell
25,305
-1,581
-6% -$85.6K ﹤0.01% 1574
2020
Q4
$1.59M Sell
26,886
-1,386
-5% -$71.5K ﹤0.01% 1247
2020
Q3
$1.38M Buy
28,272
+830
+3% +$34.9K ﹤0.01% 1160
2020
Q2
$1.33M Buy
27,442
+7,053
+35% +$257K ﹤0.01% 1161
2020
Q1
$566K Buy
+20,389
New +$569K ﹤0.01% 1551

Other funds holding ADPT

VOYA Investment Management's ADPT Position: Q2 2026 in Review

VOYA Investment Management increased its Adaptive Biotechnologies (ADPT) stake by 519% in Q2 2026, buying an estimated $3.88M and bringing the position to 302,141 shares worth $6.48M. The position accounts for 0.01% of the portfolio, ranked #767.

VOYA Investment Management first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $19.5M in Q3 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • VOYA Investment Management held 302,141 shares of Adaptive Biotechnologies worth $6.48M as of Q2 2026.
  • VOYA Investment Management bought 253,309 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.88M.
  • Adaptive Biotechnologies made up 0.01% of VOYA Investment Management's portfolio in Q2 2026, its #767 holding.
  • VOYA Investment Management first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
  • VOYA Investment Management's Adaptive Biotechnologies position peaked at $19.5M in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.